Cover Image
Market Research Report

Australia Drug Delivery Devices Market Outlook to 2023 - Central Venous Catheters, Infusion Systems, Needle Free Injections and Metered Dose Inhaler Devices

Published by GlobalData Product code 537214
Published Content info 132 Pages
Delivery time: 1-2 business days
Price
Back to Top
Australia Drug Delivery Devices Market Outlook to 2023 - Central Venous Catheters, Infusion Systems, Needle Free Injections and Metered Dose Inhaler Devices
Published: August 1, 2017 Content info: 132 Pages
Description

GlobalData's new report, "Australia Drug Delivery Devices Market Outlook to 2023", provides key market data on the Australia Drug Delivery Devices market. The report provides value, in millions of US dollars and volume (in units) within market categories - Central Venous Catheters, Needle Free Injections, Infusion Systems and Metered Dose Inhaler Devices.

The report also provides company shares and distribution shares data for each of these market categories, and global corporate-level profiles of the key market participants. Based on the availability of data for the particular market and country, information related to pipeline products, news and deals is available in the report.

Extensive interviews are conducted with key opinion leaders (KOLs), physicians and industry experts to validate the market size, company share and distribution share data and analysis.

Scope

  • Market size and company share data for Drug Delivery Devices market categories - Central Venous Catheters, Needle Free Injections, Infusion Systems and Metered Dose Inhaler Devices.
  • Annualized market revenues (USD million) and volume (units) data for each of the market categories. Data is provided from 2009 to 2016 and forecast to 2023.
  • 2016 company shares and distribution shares data for each of the market categories.
  • Global corporate-level profiles of key companies operating within the Australia Drug Delivery Devices market.
  • Key players covered include GlaxoSmithKline Plc, AstraZeneca Plc, Hospira Inc, Becton Dickinson and Co, Boehringer Ingelheim GmbH, Baxter International Inc, Medtronic plc and others.

Reasons to buy

  • Develop business strategies by identifying the key market categories poised for strong growth in the future.
  • Develop market-entry and market expansion strategies.
  • Design competition strategies by identifying who-stands-where in the market.
  • Develop investment strategies by identifying the key market categories expected to register strong growth in the near future.
  • What are the key distribution channels and what's the most preferred mode of product distribution - Identify, understand and capitalize.
Table of Contents
Product Code: GDMEMC0252DB

Table of Contents

1 Table of Contents

1 Table of Contents 2

  • 1.1 List of Tables 5
  • 1.2 List of Figures 6

2 Introduction 7

  • 2.1 What Is This Report About? 7
  • 2.2 Drug Delivery Devices Market Segmentation 7
  • 2.3 Definitions of Markets Covered in the Report 8

3 Drug Delivery Devices Market, Australia 11

  • 3.1 Drug Delivery Devices Market, Australia, Revenue ($m), 2009-2023 11
  • 3.2 Drug Delivery Devices Market, Australia, Revenue Mix ($m), 2016 13
  • 3.3 Drug Delivery Devices Market, Australia, Category Contribution by Revenue ($m), 2016 14
  • 3.4 Drug Delivery Devices Market, Australia, Category Comparison by Revenue ($m), 2009-2023 15
  • 3.5 Drug Delivery Devices Market, Australia, Revenue ($m), 2009-2016 16
  • 3.6 Drug Delivery Devices Market, Australia, Revenue ($m), 2016-2023 18
  • 3.7 Drug Delivery Devices Market, Australia, Volume (Units), 2009-2023 20
  • 3.8 Drug Delivery Devices Market, Australia, Volume (Units), 2009-2016 22
  • 3.9 Drug Delivery Devices Market, Australia, Volume (Units), 2016-2023 24
  • 3.10 Drug Delivery Devices Market, Australia, Company Share by Revenue ($m), 2016 26

4 Central Venous Catheters Market, Australia 28

  • 4.1 Central Venous Catheters Market, Australia, Revenue Mix ($m), 2016 28
  • 4.2 Central Venous Catheters Market, Australia, Segment Contribution (%), 2016 29
  • 4.3 Central Venous Catheters Market, Australia, Revenue ($m), 2009-2016 30
  • 4.4 Central Venous Catheters Market, Australia, Revenue ($m), 2016-2023 32
  • 4.5 Central Venous Catheters Market, Australia, Volume (Units), 2009-2016 34
  • 4.6 Central Venous Catheters Market, Australia, Volume (Units), 2016-2023 36
  • 4.7 Central Venous Catheters Market, Australia, Distribution Share by Revenue ($m), 2015-2016 38
  • 4.8 Central Venous Catheters Market, Australia, Company Share by Revenue ($m), 2016 39

5 Infusion Systems Market, Australia 41

  • 5.1 Infusion Systems Market, Australia, Revenue Mix ($m), 2016 41
  • 5.2 Infusion Systems Market, Australia, Segment Contribution (%), 2016 42
  • 5.3 Infusion Systems Market, Australia, Revenue ($m), 2009-2016 43
  • 5.4 Infusion Systems Market, Australia, Revenue ($m), 2016-2023 45
    • 5.4.1 Ambulatory Infusion Pumps Market, Australia, Revenue ($m), by Segment, 2009-2016 47
    • 5.4.2 Syringe Pumps Market, Australia, Revenue ($m), by Segment, 2009-2016 49
    • 5.4.3 Ambulatory Infusion Pumps Market, Australia, Revenue ($m), by Segment, 2016-2023 51
    • 5.4.4 Syringe Pumps Market, Australia, Revenue ($m), by Segment, 2016-2023 53
  • 5.5 Infusion Systems Market, Australia, Volume (Units), 2009-2016 55
  • 5.6 Infusion Systems Market, Australia, Volume (Units), 2016-2023 57
    • 5.6.1 Ambulatory Infusion Pumps Market, Australia, Volume (Units), by Segment, 2009-2016 59
    • 5.6.2 Syringe Pumps Market, Australia, Volume (Units), by Segment, 2009-2016 61
    • 5.6.3 Ambulatory Infusion Pumps Market, Australia, Volume (Units), by Segment, 2016-2023 63
    • 5.6.4 Syringe Pumps Market, Australia, Volume (Units), by Segment, 2016-2023 65
  • 5.7 Infusion Systems Market, Australia, Distribution Share by Revenue ($m), 2015-2016 67
  • 5.8 Infusion Systems Market, Australia, Company Share by Revenue ($m), 2016 68

6 Needle Free Injections Market, Australia 70

  • 6.1 Needle Free Injections Market, Australia, Revenue ($m), 2009-2016 70
  • 6.2 Needle Free Injections Market, Australia, Revenue ($m), 2016-2023 71
  • 6.3 Needle Free Injections Market, Australia, Volume (Units), 2009-2016 72
  • 6.4 Needle Free Injections Market, Australia, Volume (Units), 2016-2023 73
  • 6.5 Needle Free Injections Market, Australia, Distribution Share by Revenue ($m), 2015-2016 74
  • 6.6 Needle Free Injections Market, Australia, Company Share by Revenue ($m), 2016 75

7 Metered Dose Inhaler Devices Market, Australia 77

  • 7.1 Metered Dose Inhaler Devices Market, Australia, Revenue ($m), 2009-2016 77
  • 7.2 Metered Dose Inhaler Devices Market, Australia, Revenue ($m), 2016-2023 78
  • 7.3 Metered Dose Inhaler Devices Market, Australia, Volume (Units), 2009-2016 79
  • 7.4 Metered Dose Inhaler Devices Market, Australia, Volume (Units), 2016-2023 80
  • 7.5 Metered Dose Inhaler Devices Market, Australia, Distribution Share by Revenue ($m), 2015-2016 81
  • 7.6 Metered Dose Inhaler Devices Market, Australia, Company Share by Revenue ($m), 2016 82

8 Overview of Key Companies in Australia, Drug Delivery Devices Market 84

  • 8.1 Teleflex Inc 84
    • 8.1.1 Company Overview 84
  • 8.2 GlaxoSmithKline Plc 84
    • 8.2.1 Company Overview 84
  • 8.3 AstraZeneca Plc 84
    • 8.3.1 Company Overview 84
  • 8.4 Becton Dickinson and Co 84
    • 8.4.1 Company Overview 84
  • 8.5 Boehringer Ingelheim GmbH 85
    • 8.5.1 Company Overview 85
  • 8.6 Baxter International Inc 85
    • 8.6.1 Company Overview 85
  • 8.7 Fresenius Kabi AG 85
    • 8.7.1 Company Overview 85
  • 8.8 Pfizer Inc 86
    • 8.8.1 Company Overview 86
  • 8.9 B. Braun Melsungen AG 86
    • 8.9.1 Company Overview 86
  • 8.10 Smiths Medical 86
    • 8.10.1 Company Overview 86
  • 8.11 Merck & Co Inc 87
    • 8.11.1 Company Overview 87
  • 8.12 Hospira Inc 87
    • 8.12.1 Company Overview 87
  • 8.13 Terumo Corp 87
    • 8.13.1 Company Overview 87
  • 8.14 Nipro Corp 87
    • 8.14.1 Company Overview 87
  • 8.15 Medtronic plc 88
    • 8.19.1 Company Overview 88

9 Drug Delivery Devices Market Pipeline Products 89

10 Financial Deals Landscape 94

  • 10.1 Asset Transactions 94
    • 10.1.1 ICU Medical Acquires Hospira Infusion Systems Business from Pfizer 94
  • 10.2 Debt Offerings 96
    • 10.2.1 Suda to Raise USD0.6 Million in Public Offering of 8% Convertible Notes Due March 2019 96
  • 10.3 Equity Offerings 97
    • 10.3.1 Suda Raises USD1.1 Million in Private Placement of Shares 97
    • 10.3.2 Admedus Raises USD7.5 Million in Private Placement of Shares 99
    • 10.3.3 Admedus Raises USD4 Million in Rights Offering of Shares 100
  • 10.4 Partnerships 101
    • 10.4.1 Aequus Pharma to Enter into Licensing Agreement with Transdermal Research Pharm Labs 101
    • 10.4.2 Valeant Pharma Enters into Licensing Agreement with EyeGate Pharma 102
    • 10.4.3 Pfizer Terminates its Licensing Agreement with pSivida 104
    • 10.4.4 Bayer Enters into Licensing Agreement with DelSiTech 105
    • 10.4.5 BioCorRx Enters into Licensing Agreement with Therakine 106

11 Recent Developments 107

  • 11.1 Corporate Communications 107
    • 11.1.1 Jun 09, 2017: Admedus Appoints David St. Denis as Chief Operating Officer 107
    • 11.1.2 May 23, 2017: Analytica: Appointment of Dr. Peter B. Corr as Director 107
    • 11.1.3 Apr 21, 2017: Phosphagenics Announces Transition of Chairman of the Board 108
    • 11.1.4 Apr 04, 2017: GSK responds to Cyclone Debbie 109
    • 11.1.5 Mar 15, 2017: Admedus Appoints Wayne Paterson As Chief Executive Officer 109
    • 11.1.6 Mar 14, 2017: Admedus Appoints John Seaberg As Chairman 110
    • 11.1.7 Dec 12, 2016: Cologuard Available to Humana Members as In-Network Colon Cancer Screening Option 111
    • 11.1.8 Dec 08, 2016: Acrux Announces Director Resignation 112
    • 11.1.9 Oct 17, 2016: Medrobotics Corporation Receives Expanded CE Mark for Flex Robotic System 112
    • 11.1.10 Sep 25, 2016: Admedus Strengthens Management Team 113
    • 11.1.11 Sep 15, 2016: Anne Belcher to succeed Geoff McDonald as GSK Australia general manager 113
    • 11.1.12 Aug 26, 2016: Admedus Appoints New Chief Financial Officer 114
  • 11.2 Financial Announcements 114
    • 11.2.1 May 02, 2017: GSK Australia Reports 2016 results to ASIC 114
    • 11.2.2 Apr 28, 2017: Clinuvel Pharmaceuticals: Appendix 4C - Quarterly report 115
    • 11.2.3 Feb 28, 2017: Phosphagenics Full Year Financial Results 116
    • 11.2.4 Feb 24, 2017: Admedus Announces Half Yearly Report 117
    • 11.2.5 Feb 23, 2017: ITL Profit Doubles In Half Year 2016/2017 Results 118
    • 11.2.6 Feb 20, 2017: Medical Developments Reports Revenue Of AUD8m In H1 Fiscal 2017 118
    • 11.2.7 Oct 31, 2016: Suda: Appendix 4C For First Quarter Fy 2017 119
    • 11.2.8 Oct 28, 2016: Analytica: Appendix 4C - Quarterly Cash Flow Report 119
    • 11.2.9 Aug 31, 2016: Analytica Announces 2016 Full Year Results 119
    • 11.2.10 Aug 24, 2016: Acrux: Financial Report for the year ended 30 June 2016 120
    • 11.2.11 Jul 20, 2016: Admedus Announces Financial Report 121
  • 11.3 Legal And Regulatory 122
    • 11.3.1 May 29, 2017: Phosphagenic - Mylan Arbitration Update - expert report on quantum of damages claimed filed 122
    • 11.3.2 Jan 20, 2017: Change of Registered Office and Principal Place of Business 122
    • 11.3.3 Sep 09, 2016: Admedus Announces Settlement Of Federal Court Proceedings 122
  • 11.4 Other Significant Developments 123
    • 11.4.1 Apr 26, 2017: Axiron Net Sales, quarter to March 2017 123
    • 11.4.2 Apr 13, 2017: PreveCeutical Signs Letter of Intent for Research & Development for Cannabinoid and Diabetes Products with UniQuest 123
    • 11.4.3 Mar 07, 2017: Anteo Technologies Announces Verification Study With Cook Medical Australia 124
    • 11.4.4 Jan 31, 2017: Analytica Releases Quarterly Cash Flow Report 125
    • 11.4.5 Dec 23, 2016: Admedus Finishes Year With Growing Revenue After Completing Code Red Review 125
    • 11.4.6 Oct 28, 2016: Starpharma Quarterly Cashflow Report 126
  • 11.5 Product News 127
    • 11.5.1 Oct 26, 2016: Starpharma to present at US Drug Delivery Conference 127

12 Appendix 128

  • 12.1 Research Methodology 129
    • 12.1.1 Coverage 129
    • 12.1.2 Secondary Research 129
    • 12.1.3 Primary Research 130
    • 12.1.4 Company Share Analysis 130
    • 12.1.5 Distribution Share Analysis 130
    • 12.1.6 Benchmarking 131
  • 12.2 GlobalData Consulting 131
  • 12.3 Contact Us 132
  • 12.4 Disclaimer 132

List of Tables

1.1 List of Tables

  • Table 1: Drug Delivery Devices Market, Australia, Revenue ($m), USD Constant, 2009-2023 12
  • Table 2: Drug Delivery Devices Market, Australia, Category Contribution by Revenue ($m), 2016 14
  • Table 3: Drug Delivery Devices Market, Australia, Category Comparison by Revenue ($m), 2009-2023 15
  • Table 4: Drug Delivery Devices Market, Australia, Revenue ($m), USD Constant, Historic, 2009-2016 17
  • Table 5: Drug Delivery Devices Market, Australia, Revenue ($m), USD Constant, Forecast, 2016-2023 19
  • Table 6: Drug Delivery Devices Market, Australia, Volume (Units), 2009-2023 21
  • Table 7: Drug Delivery Devices Market, Australia, Volume (Units), Historic, 2009-2016 23
  • Table 8: Drug Delivery Devices Market, Australia, Volume (Units), Forecast, 2016-2023 25
  • Table 9: Drug Delivery Devices Market, Australia, Company Share by Revenue ($m), USD Constant, 2016 27
  • Table 10: Central Venous Catheters Market, Australia, Segment Contribution (%), 2016 29
  • Table 11: Central Venous Catheters Market, Australia, Revenue ($m), USD Constant, Historic, 2009-2016 31
  • Table 12: Central Venous Catheters Market, Australia, Revenue ($m), USD Constant, Forecast, 2016-2023 33
  • Table 13: Central Venous Catheters Market, Australia, Volume (Units), Historic, 2009-2016 35
  • Table 14: Central Venous Catheters Market, Australia, Volume (Units), Forecast, 2016-2023 37
  • Table 15: Central Venous Catheters Market, Australia, Distribution Share by Revenue ($m), USD Constant, 2015-2016 38
  • Table 16: Central Venous Catheters Market, Australia, Company Share by Revenue ($m), USD Constant, 2016 40
  • Table 17: Infusion Systems Market, Australia, Segment Contribution (%), 2016 42
  • Table 18: Infusion Systems Market, Australia, Revenue ($m), USD Constant, Historic, 2009-2016 44
  • Table 19: Infusion Systems Market, Australia, Revenue ($m), USD Constant, Forecast, 2016-2023 46
  • Table 20: Ambulatory Infusion Pumps Market, Australia, Revenue ($m), USD Constant, Historic, 2009-2016 48
  • Table 21: Syringe Pumps Market, Australia, Revenue ($m), USD Constant, Historic, 2009-2016 50
  • Table 22: Ambulatory Infusion Pumps Market, Australia, Revenue ($m), USD Constant, Forecast, 2016-2023 52
  • Table 23: Syringe Pumps Market, Australia, Revenue ($m), USD Constant, Forecast, 2016-2023 54
  • Table 24: Infusion Systems Market, Australia, Volume (Units), Historic, 2009-2016 56
  • Table 25: Infusion Systems Market, Australia, Volume (Units), Forecast, 2016-2023 58
  • Table 26: Ambulatory Infusion Pumps Market, Australia, Volume (Units), Historic, 2009-2016 60
  • Table 27: Syringe Pumps Market, Australia, Volume (Units), Historic, 2009-2016 62
  • Table 28: Ambulatory Infusion Pumps Market, Australia, Volume (Units), Forecast, 2016-2023 64
  • Table 29: Syringe Pumps Market, Australia, Volume (Units), Forecast, 2016-2023 66
  • Table 30: Infusion Systems Market, Australia, Distribution Share by Revenue ($m), USD Constant, 2015-2016 67
  • Table 31: Infusion Systems Market, Australia, Company Share by Revenue ($m), USD Constant, 2016 69
  • Table 32: Needle Free Injections Market, Australia, Revenue ($m), USD Constant, Historic, 2009-2016 70
  • Table 33: Needle Free Injections Market, Australia, Revenue ($m), USD Constant, Forecast, 2016-2023 71
  • Table 34: Needle Free Injections Market, Australia, Volume (Units), Historic, 2009-2016 72
  • Table 35: Needle Free Injections Market, Australia, Volume (Units), Forecast, 2016-2023 73
  • Table 36: Needle Free Injections Market, Australia, Distribution Share by Revenue ($m), USD Constant, 2015-2016 74
  • Table 37: Needle Free Injections Market, Australia, Company Share by Revenue ($m), USD Constant, 2016 76
  • Table 38: Metered Dose Inhaler Devices Market, Australia, Revenue ($m), USD Constant, Historic, 2009-2016 77
  • Table 39: Metered Dose Inhaler Devices Market, Australia, Revenue ($m), USD Constant, Forecast, 2016-2023 78
  • Table 40: Metered Dose Inhaler Devices Market, Australia, Volume (Units), Historic, 2009-2016 79
  • Table 41: Metered Dose Inhaler Devices Market, Australia, Volume (Units), Forecast, 2016-2023 80
  • Table 42: Metered Dose Inhaler Devices Market, Australia, Distribution Share by Revenue ($m), USD Constant, 2015-2016 81
  • Table 43: Metered Dose Inhaler Devices Market, Australia, Company Share by Revenue ($m), USD Constant, 2016 83
  • Table 44: Drug Delivery Devices Market Pipeline Products 89
  • Table 45: ICU Medical Acquires Hospira Infusion Systems Business from Pfizer 94
  • Table 46: Suda to Raise USD0.6 Million in Public Offering of 8% Convertible Notes Due March 2019 96
  • Table 47: Suda Raises USD1.1 Million in Private Placement of Shares 97
  • Table 48: Admedus Raises USD7.5 Million in Private Placement of Shares 99
  • Table 49: Admedus Raises USD4 Million in Rights Offering of Shares 100
  • Table 50: Aequus Pharma to Enter into Licensing Agreement with Transdermal Research Pharm Labs 101
  • Table 51: Valeant Pharma Enters into Licensing Agreement with EyeGate Pharma 102
  • Table 52: Pfizer Terminates its Licensing Agreement with pSivida 104
  • Table 53: Bayer Enters into Licensing Agreement with DelSiTech 105
  • Table 54: BioCorRx Enters into Licensing Agreement with Therakine 106

List of Figures

1.2 List of Figures

  • Figure 1: Drug Delivery Devices Market, Australia, Revenue ($m), USD Constant, 2009-2023 11
  • Figure 2: Drug Delivery Devices Market, Australia, Revenue Mix ($m), 2016 13
  • Figure 3: Drug Delivery Devices Market, Australia, Category Contribution (%), 2016 14
  • Figure 4: Drug Delivery Devices Market, Australia, Category Comparison by Revenue ($m), 2009-2023 15
  • Figure 5: Drug Delivery Devices Market, Australia, Revenue ($m), USD Constant, Historic, 2009-2016 16
  • Figure 6: Drug Delivery Devices Market, Australia, Revenue ($m), USD Constant, Forecast, 2016-2023 18
  • Figure 7: Drug Delivery Devices Market, Australia, Volume (Units), 2009-2023 20
  • Figure 8: Drug Delivery Devices Market, Australia, Volume (Units), Historic, 2009-2016 22
  • Figure 9: Drug Delivery Devices Market, Australia, Volume (Units), Forecast, 2016-2023 24
  • Figure 10: Drug Delivery Devices Market, Australia, Company Share (%) 2016 26
  • Figure 11: Central Venous Catheters Market, Australia, Revenue Mix ($m), 2016 28
  • Figure 12: Central Venous Catheters Market, Australia, Segment Contribution (%), 2016 29
  • Figure 13: Central Venous Catheters Market, Australia, Revenue ($m), USD Constant, Historic, 2009-2016 30
  • Figure 14: Central Venous Catheters Market, Australia, Revenue ($m), USD Constant, Forecast, 2016-2023 32
  • Figure 15: Central Venous Catheters Market, Australia, Volume (Units), Historic, 2009-2016 34
  • Figure 16: Central Venous Catheters Market, Australia, Volume (Units), Forecast, 2016-2023 36
  • Figure 17: Central Venous Catheters Market, Australia, Company Share (%) 2016 39
  • Figure 18: Infusion Systems Market, Australia, Revenue Mix ($m), 2016 41
  • Figure 19: Infusion Systems Market, Australia, Segment Contribution (%), 2016 42
  • Figure 20: Infusion Systems Market, Australia, Revenue ($m), USD Constant, Historic, 2009-2016 43
  • Figure 21: Infusion Systems Market, Australia, Revenue ($m), USD Constant, Forecast, 2016-2023 45
  • Figure 22: Ambulatory Infusion Pumps Market, Australia, Revenue ($m), USD Constant, Historic, 2009-2016 47
  • Figure 23: Syringe Pumps Market, Australia, Revenue ($m), USD Constant, Historic, 2009-2016 49
  • Figure 24: Ambulatory Infusion Pumps Market, Australia, Revenue ($m), USD Constant, Forecast, 2016-2023 51
  • Figure 25: Syringe Pumps Market, Australia, Revenue ($m), USD Constant, Forecast, 2016-2023 53
  • Figure 26: Infusion Systems Market, Australia, Volume (Units), Historic, 2009-2016 55
  • Figure 27: Infusion Systems Market, Australia, Volume (Units), Forecast, 2016-2023 57
  • Figure 28: Ambulatory Infusion Pumps Market, Australia, Volume (Units), Historic, 2009-2016 59
  • Figure 29: Syringe Pumps Market, Australia, Volume (Units), Historic, 2009-2016 61
  • Figure 30: Ambulatory Infusion Pumps Market, Australia, Volume (Units), Forecast, 2016-2023 63
  • Figure 31: Syringe Pumps Market, Australia, Volume (Units), Forecast, 2016-2023 65
  • Figure 32: Infusion Systems Market, Australia, Company Share (%) 2016 68
  • Figure 33: Needle Free Injections Market, Australia, Revenue ($m), USD Constant, Historic, 2009-2016 70
  • Figure 34: Needle Free Injections Market, Australia, Revenue ($m), USD Constant, Forecast, 2016-2023 71
  • Figure 35: Needle Free Injections Market, Australia, Volume (Units), Historic, 2009-2016 72
  • Figure 36: Needle Free Injections Market, Australia, Volume (Units), Forecast, 2016-2023 73
  • Figure 37: Needle Free Injections Market, Australia, Company Share (%) 2016 75
  • Figure 38: Metered Dose Inhaler Devices Market, Australia, Revenue ($m), USD Constant, Historic, 2009-2016 77
  • Figure 39: Metered Dose Inhaler Devices Market, Australia, Revenue ($m), USD Constant, Forecast, 2016-2023 78
  • Figure 40: Metered Dose Inhaler Devices Market, Australia, Volume (Units), Historic, 2009-2016 79
  • Figure 41: Metered Dose Inhaler Devices Market, Australia, Volume (Units), Forecast, 2016-2023 80
  • Figure 42: Metered Dose Inhaler Devices Market, Australia, Company Share (%) 2016 82
Back to Top